SciELO - Scientific Electronic Library Online

 
vol.23 issue4Risk stratification for coronary disease in old adultsAtrial fibrillation as initial feature of Brugada syndrome: a case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Cardiología

Print version ISSN 0120-5633

Abstract

ADAMS-SANCHEZ, Christian David  and  TOBON-GARCIA, Gabriel Jaime. Monoclonal antibody therapy in Cardiology and Internal Medicine. Rev. Colomb. Cardiol. [online]. 2016, vol.23, n.4, pp.293-300. ISSN 0120-5633.  https://doi.org/10.1016/j.rccar.2016.02.003.

The monoclonal antibodies (mAb) constitute a new therapeutic tool in cardiovascular medicine, based in the development of the molecular biology in this area. The understanding of therapeutic principles, types and mechanism of action of these drugs is essential for proper use and management of adverse reactions. We discuss the profile of the PCSK-9 inhibitors, the Dabigatran antidote, the abciximab, the digoxin antidote, the therapy in heart transplantation, and a possible cardiovascular use of monoclonal antibodies used in rheumatology.

Keywords : Pharmacology; Immunology; Antibodies; Cardiovascular diseases; Low density lipoproteins cholesterol.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License